Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Vornorexant is a dual orexin receptor antagonist (DORA).1 It inhibits [Ala6,12]-orexin A-induced calcium mobilization in CHO-K1 cells expressing recombinant human orexin receptor 1 (OX1R) or OX2R (IC50s = 1.05 and 1.27 nM, respectively). Vornorexant (1, 3, and 10 mg/kg, p.o.) decreases sleep latency and increases total sleep in rats. Formulations containing vornorexant have been used in the treatment of insomnia.
WARNING This product is not for human or veterinary use.
1. Discovery of ORN0829, a potent dual orexin ½ receptor antagonist for the treatment of insomnia. Bioorg. Med. Chem. 28(12), 115489 (2020).